Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,354 public trials 2,837 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, Not Recruiting

A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors

NCT05135559

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Rady Childrens Hosp San Diego San Diego, California, United States
  • University of Colorado Hospital Aurora, Colorado, United States
  • Arnold Palmer Children's Hospital Orlando, Florida, United States
  • Nemours Child Orlando Hem/Onc. Orlando, Florida, United States
View all 91 locations
View Trial Details
Active, Not Recruiting

A Long-term Safety and Efficacy Study of Danicopan as an Add-on Therapy to Complement Component 5 Inhibitor (C5i) in Participants With PNH

NCT05389449

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +8 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Baltimore, Maryland, United States
  • Research Site Kansas City, Missouri, United States
View all 45 locations
View Trial Details
Active, Not Recruiting

REAl-world Outcomes in CHronic Lymphocytic Leukemia Patients Receiving Acalabrutinib in Romania

NCT06170671

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Research Site Piteşti, Argeş, Romania
  • Research Site Oradea, Bihor County, Romania
  • Research Site Cluj-Napoca, Cluj, Romania
  • Research Site Craiova, Dolj, Romania
View all 19 locations
View Trial Details
Active, Not Recruiting

Extended Access of Momelotinib in Adults With Myelofibrosis

NCT03441113

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • GSK Investigational Site Scottsdale, Arizona, United States
  • GSK Investigational Site Orange, California, United States
  • GSK Investigational Site Stanford, California, United States
  • GSK Investigational Site Aurora, Colorado, United States
View all 112 locations
View Trial Details
Active, Not Recruiting

Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia

NCT01841723

Conditions
Hairy Cell Leukemia, Hairy Cell Leukemia Variant, Hematologic Diseases, +11 more
Locations
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details

Related conditions